E2F6 and central nervous system cancer: Furthermore, the immumohistochemical (IHC) staining of 31 WHO II patients, 32 WHO III patients, and 54 WHO IV patients proved that elevated levels of E2F6 expression are associated with high grade of glioma (Figure 3c).